Single- And Repeated-Dose Inhalation Toxicity of Medicinal Cigarettes with Antitussive and Expectorants in ICR Mice

ABSTRACT Antitussives suppress coughing, possibly by reducing brain cough center activity, while expectorants thin mucus to help loosen congestion and clear airways. Inhaling antitussives and expectorants, involving using inhaled vapors or aerosolized medications to manage cough and mucus, allow for direct inhalation into the respiratory tract to provide faster relief. However, the reported adverse effects raised question as to whether inhaling antitussives and expectorants directly can pose risks. Therefore, the present study aimed to assess the toxicological profile of medicinal cigarette with antitussive and expectorants, though single- and repeated-dose toxicity test. Male and female ICR mice were received by whole-body inhalation at target mainstream smoke concentrations of 95 mg/m3 total particulate matter (TPM) of medicinal cigarette with antitussive and expectorants in the single-dose toxicity test. In the repeated-dose toxicity study, no mortality or behavioral signs of toxicity were observed, indicating the LD50 was higher than 95 mg/m3 in the exposure period and the following 2 weeks observation period. In the repeated-dose inhalation toxicity study, the potential toxic effects of medicinal cigarette with antitussive and expectorants were examined using ICR mice exposed for 4 weeks, by whole-body inhalation at target mainstream smoke concentrations of 15.7, 27.9 and 47.5 mg/m3 TPM, while control rats were exposed to filtered air. There was no significant difference observed in the body weights, feed consumption, relative organ weights, haematological, prothrombin and partial thromboplastin time, and serum biochemical findings. The histopathologic examination also did not show any differences in vital organs. These data suggested that medicinal cigarette with antitussive and expectorants used in this study did not produce any marked repeated-dose toxic effects up to a maximum concentration of 47.5 mg/m3 TPM.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-06-09
DOI
https://doi.org/10.5281/zenodo.20605875
Primary Topic
Smoking Behavior and Cessation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Single- And Repeated-Dose Inhalation Toxicity of Medicinal Cigarettes with Antitussive and Expectorants in ICR Mice

M J Kim
Zenodo (CERN European Organization for Nuclear Research)
Smoking Behavior and Cessation
article

Single- And Repeated-Dose Inhalation Toxicity of Medicinal Cigarettes with Antitussive and Expectorants in ICR Mice

M J Kim
article en

Abstract

ABSTRACT Antitussives suppress coughing, possibly by reducing brain cough center activity, while expectorants thin mucus to help loosen congestion and clear airways. Inhaling antitussives and expectorants, involving using inhaled vapors or aerosolized medications to manage cough and mucus, allow for direct inhalation into the respiratory tract to provide faster relief. However, the reported adverse effects raised question as to whether inhaling antitussives and expectorants directly can pose risks. Therefore, the present study aimed to assess the toxicological profile of medicinal cigarette with antitussive and expectorants, though single- and repeated-dose toxicity test. Male and female ICR mice were received by whole-body inhalation at target mainstream smoke concentrations of 95 mg/m3 total particulate matter (TPM) of medicinal cigarette with antitussive and expectorants in the single-dose toxicity test. In the repeated-dose toxicity study, no mortality or behavioral signs of toxicity were observed, indicating the LD50 was higher than 95 mg/m3 in the exposure period and the following 2 weeks observation period. In the repeated-dose inhalation toxicity study, the potential toxic effects of medicinal cigarette with antitussive and expectorants were examined using ICR mice exposed for 4 weeks, by whole-body inhalation at target mainstream smoke concentrations of 15.7, 27.9 and 47.5 mg/m3 TPM, while control rats were exposed to filtered air. There was no significant difference observed in the body weights, feed consumption, relative organ weights, haematological, prothrombin and partial thromboplastin time, and serum biochemical findings. The histopathologic examination also did not show any differences in vital organs. These data suggested that medicinal cigarette with antitussive and expectorants used in this study did not produce any marked repeated-dose toxic effects up to a maximum concentration of 47.5 mg/m3 TPM.

Zenodo (CERN European Organization for Nuclear Research)
Jeju National University (KR)
Good health and well-being
Openalex Percentile: Top 7%
Smoking Behavior and Cessation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.